These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16569821)

  • 21. The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin.
    Tsai FT; Singh OM; Skarzynski T; Wonacott AJ; Weston S; Tucker A; Pauptit RA; Breeze AL; Poyser JP; O'Brien R; Ladbury JE; Wigley DB
    Proteins; 1997 May; 28(1):41-52. PubMed ID: 9144789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.
    Jakopin Ž; Ilaš J; Barančoková M; Brvar M; Tammela P; Sollner Dolenc M; Tomašič T; Kikelj D
    Eur J Med Chem; 2017 Apr; 130():171-184. PubMed ID: 28246042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of gyrase B. L-rhamnose as an effective substitute for L-noviose.
    Ferroud D; Collard J; Klich M; Dupuis-Hamelin C; Mauvais P; Lassaigne P; Bonnefoy A; Musicki B
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2881-6. PubMed ID: 10522711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors.
    Hashem HE; Amr AEE; Nossier ES; Elsayed EA; Azmy EM
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization.
    Hsu YH; Chung MW; Li TK
    Nucleic Acids Res; 2006; 34(10):3128-38. PubMed ID: 16757578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New aminocoumarin antibiotics from a cloQ-defective mutant of the clorobiocin producer Streptomyces roseochromogenes DS12.976.
    Freitag A; Galm U; Li SM; Heide L
    J Antibiot (Tokyo); 2004 Mar; 57(3):205-9. PubMed ID: 15152806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biosynthetic gene clusters of aminocoumarin antibiotics.
    Li SM; Heide L
    Planta Med; 2006 Oct; 72(12):1093-9. PubMed ID: 16868863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.
    Hardy CD; Cozzarelli NR
    Antimicrob Agents Chemother; 2003 Mar; 47(3):941-7. PubMed ID: 12604525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
    Metwally NH; Abdallah SO; Mohsen MMA
    Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action.
    Flatman RH; Howells AJ; Heide L; Fiedler HP; Maxwell A
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1093-100. PubMed ID: 15728908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
    Cheng J; Thanassi JA; Thoma CL; Bradbury BJ; Deshpande M; Pucci MJ
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2445-53. PubMed ID: 17502409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.
    Tabary X; Moreau N; Dureuil C; Le Goffic F
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1925-8. PubMed ID: 2830840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the noviose.
    Lafitte D; Lamour V; Tsvetkov PO; Makarov AA; Klich M; Deprez P; Moras D; Briand C; Gilli R
    Biochemistry; 2002 Jun; 41(23):7217-23. PubMed ID: 12044152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminocoumarins mutasynthesis, chemoenzymatic synthesis, and metabolic engineering.
    Heide L
    Methods Enzymol; 2009; 459():437-55. PubMed ID: 19362650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90.
    Burlison JA; Neckers L; Smith AB; Maxwell A; Blagg BS
    J Am Chem Soc; 2006 Dec; 128(48):15529-36. PubMed ID: 17132020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase/topoisomerase IV inhibition.
    Ismail MMF; Abdulwahab HG; Nossier ES; El Menofy NG; Abdelkhalek BA
    Bioorg Chem; 2020 Jan; 94():103437. PubMed ID: 31812260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New aminocoumarin antibiotics formed by a combined mutational and chemoenzymatic approach utilizing the carbamoyltransferase NovN.
    Xu H; Heide L; Li SM
    Chem Biol; 2004 May; 11(5):655-62. PubMed ID: 15157876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV.
    Pan XS; Gould KA; Fisher LM
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3822-31. PubMed ID: 19564360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic engineering of antibiotic biosynthesis for the generation of new aminocoumarins.
    Heide L
    Biotechnol Adv; 2009; 27(6):1006-1014. PubMed ID: 19463934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
    Mitton-Fry MJ; Brickner SJ; Hamel JC; Brennan L; Casavant JM; Chen M; Chen T; Ding X; Driscoll J; Hardink J; Hoang T; Hua E; Huband MD; Maloney M; Marfat A; McCurdy SP; McLeod D; Plotkin M; Reilly U; Robinson S; Schafer J; Shepard RM; Smith JF; Stone GG; Subramanyam C; Yoon K; Yuan W; Zaniewski RP; Zook C
    Bioorg Med Chem Lett; 2013 May; 23(10):2955-61. PubMed ID: 23566517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.